J. Goldman & Co LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 134 filers reported holding PTC THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$10,897,000
+541.4%
653,284
+669.7%
0.57%
+565.1%
Q3 2017$1,699,000
-56.8%
84,880
-60.4%
0.09%
-59.6%
Q2 2017$3,930,000
-73.2%
214,380
-85.6%
0.21%
-70.7%
Q1 2017$14,678,000
+1823.7%
1,491,722
+2032.6%
0.73%
+1323.5%
Q4 2016$763,000
+19.8%
69,950
+568.4%
0.05%
+30.8%
Q1 2015$637,00010,4660.04%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders